Q2 2021
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FATE | New | FATE THERAPEUTICS, INC. | $293,269,000 | – | 3,379,064 | – | 29.98% | – |
| ARWR | New | ARROWHEAD PHARMACEUTICALS | $270,065,000 | – | 3,260,869 | – | 27.61% | – |
| PTGX | New | PROTAGONIST THERAPEUTICS INC. | $109,919,000 | – | 2,449,183 | – | 11.24% | – |
| CVRX | New | CVRX, INC. | $97,876,000 | – | 3,495,575 | – | 10.01% | – |
| LEGN | New | LEGEND BIOTECH CORPORATIONsponsored ads | $66,878,000 | – | 1,629,173 | – | 6.84% | – |
| MGTX | New | MEIRAGTX HOLDINGS PLC | $44,928,000 | – | 2,898,550 | – | 4.59% | – |
| FUSN | New | FUSION PHARMACEUTICALS INC. | $29,658,000 | – | 3,670,516 | – | 3.03% | – |
| VOR | New | VOR BIOPHARMA, INC. | $20,042,000 | – | 1,074,658 | – | 2.05% | – |
| PHGE | New | BIOMX INC. | $11,648,000 | – | 2,133,402 | – | 1.19% | – |
| RACA | New | THERAPEUTICS ACQUISITION COR | $10,274,000 | – | 1,000,000 | – | 1.05% | – |
| ACET | New | ADICET BIO, INC. | $7,501,000 | – | 728,944 | – | 0.77% | – |
| PHAS | New | PHASEBIO PHARMACEUTICALS, INC. | $5,978,000 | – | 1,607,044 | – | 0.61% | – |
| ALDX | New | ALDEYRA THERAPEUTICS, INC. | $4,473,000 | – | 394,834 | – | 0.46% | – |
| CSLT | New | CASTLIGHT HEALTH INC.cl b | $2,134,000 | – | 811,295 | – | 0.22% | – |
| NPCE | New | NEUROPACE, INC. | $1,319,000 | – | 55,435 | – | 0.14% | – |
| ZY | New | ZYMERGEN INC. | $662,000 | – | 16,553 | – | 0.07% | – |
| TCON | New | TRACON PHARMACEUTICALS, INC. | $545,000 | – | 84,003 | – | 0.06% | – |
| CBIO | New | CATALYST BIOSCIENCES, INC. | $290,000 | – | 66,951 | – | 0.03% | – |
| GRAY | New | GRAYBUG VISION, INC. | $269,000 | – | 49,547 | – | 0.03% | – |
| LUNG | New | PULMONX CORPORATION | $249,000 | – | 5,639 | – | 0.02% | – |
| SENS | New | SENSEONICS HOLDINGS, INC. | $210,000 | – | 54,621 | – | 0.02% | – |
Q4 2020
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GNCA | Exit | Genocea Biosciences, Inc. | $0 | – | -43,177 | – | -0.02% | – |
| SENS | Exit | Senseonics Holdings, Inc. | $0 | – | -525,632 | – | -0.04% | – |
| CBIO | Exit | Catalyst Biosciences, Inc. | $0 | – | -66,951 | – | -0.06% | – |
| TCON | Exit | Tracon Pharmaceuticals, Inc. | $0 | – | -84,003 | – | -0.09% | – |
| CSLT | Exit | Castlight Health Inc.cl b | $0 | – | -811,295 | – | -0.18% | – |
| ALDX | Exit | Aldeyra Therapeutics, Inc. | $0 | – | -594,834 | – | -0.89% | – |
| PHAS | Exit | PhaseBio Pharmaceuticals, Inc. | $0 | – | -1,607,044 | – | -1.14% | – |
| PRVB | Exit | Provention Bio, Inc. | $0 | – | -574,973 | – | -1.48% | – |
| ACET | Exit | Adicet Bio, Inc. | $0 | – | -662,676 | – | -1.59% | – |
| PHGE | Exit | BiomX Inc. | $0 | – | -2,133,402 | – | -2.72% | – |
| MGTX | Exit | MeiraGTx Holdings plc | $0 | – | -2,898,550 | – | -7.72% | – |
| FUSN | Exit | Fusion Pharmaceuticals Inc. | $0 | – | -3,670,516 | – | -8.88% | – |
| PTGX | Exit | Protagonist Therapeutics Inc. | $0 | – | -2,449,183 | – | -9.64% | – |
| LEGN | Exit | Legend Biotech Corporationsponsored ads | $0 | – | -1,629,173 | – | -10.12% | – |
| FATE | Exit | Fate Therapeutics, Inc. | $0 | – | -3,379,064 | – | -27.18% | – |
| ARWR | Exit | Arrowhead Pharmaceuticals | $0 | – | -3,260,869 | – | -28.26% | – |
Q3 2020
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ACET | New | Adicet Bio, Inc. | $7,879,000 | – | 662,676 | – | 1.59% | – |
| PRVB | Sell | Provention Bio, Inc. | $7,377,000 | -53.5% | 574,973 | -48.9% | 1.48% | -52.4% |
| GNCA | Sell | Genocea Biosciences, Inc. | $99,000 | -70.1% | 43,177 | -70.0% | 0.02% | -69.2% |
Q2 2020
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ARWR | New | Arrowhead Pharmaceuticals | $140,837,000 | – | 3,260,869 | – | 27.67% | – |
| FATE | New | Fate Therapeutics, Inc. | $115,936,000 | – | 3,379,064 | – | 22.77% | – |
| LEGN | New | Legend Biotech Corporationsponsored ads | $69,338,000 | – | 1,629,173 | – | 13.62% | – |
| FUSN | New | Fusion Pharmaceuticals Inc. | $64,124,000 | – | 3,670,516 | – | 12.60% | – |
| PTGX | New | Protagonist Therapeutics Inc. | $43,253,000 | – | 2,449,183 | – | 8.50% | – |
| MGTX | New | MeiraGTx Holdings plc | $36,290,000 | – | 2,898,550 | – | 7.13% | – |
| PRVB | New | Provention Bio, Inc. | $15,873,000 | – | 1,124,973 | – | 3.12% | – |
| PHGE | New | BiomX Inc. | $11,776,000 | – | 2,133,402 | – | 2.31% | – |
| PHAS | New | PhaseBio Pharmaceuticals, Inc. | $7,392,000 | – | 1,607,044 | – | 1.45% | – |
| ALDX | New | Aldeyra Therapeutics, Inc. | $2,480,000 | – | 594,834 | – | 0.49% | – |
| CSLT | New | Castlight Health Inc.cl b | $673,000 | – | 811,295 | – | 0.13% | – |
| CBIO | New | Catalyst Biosciences, Inc. | $393,000 | – | 66,951 | – | 0.08% | – |
| GNCA | New | Genocea Biosciences, Inc. | $331,000 | – | 143,964 | – | 0.06% | – |
| SENS | New | Senseonics Holdings, Inc. | $205,000 | – | 525,632 | – | 0.04% | – |
| TCON | New | Tracon Pharmaceuticals, Inc. | $165,000 | – | 84,003 | – | 0.03% | – |